Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
PBM and Insurer Groups Testify Against Bill Limiting Midyear Formulary Changes
Summary
Opponents including the Pharmaceutical Care Management Association and Ohio Association of Health Plans told the Senate committee that Senate Bill 160, intended to limit nonmedical switching midyear, could raise costs for employers and plans and complicate formulary management.
Sean Stevenson, representing the Pharmaceutical Care Management Association (PCMA), testified in opposition to Senate Bill 160, which the bill sponsor says would prevent nonmedical switching of prescription drugs during a plan year. "The intent of Senate Bill 160 is to prevent non medical switching of prescription drugs during a planned year," Stevenson said, adding that prescription drug formularies sometimes change during the year due to new medications, generics, safety updates or price changes.
Stevenson warned…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
